A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 in Cystic Fibrosis Save

Date Added
November 24th, 2015
PRO Number
Pro00049991
Researcher
Patrick Flume
Keywords
Cystic Fibrosis, Drug Studies, Inflammation, Lung, Pulmonary
Summary

This study examines the effectiveness of JBT-101 as a therapy for inflammation in Cystic Fibrosis. JBT-101 is an investigational drug that has been designed to ?resolve? or ?turn-off? active immune responses and inflammation and to stop tissue scarring from getting worse, returning the body to a more normal state. The chemical structure of JBT-101 is similar to the breakdown product of a chemical in marijuana called cannaboids. JBT-101 has been designed to avoid the ?high feeling? of marijuana.

Institution
MUSC
Recruitment Contact
Ashley Warden
843-792-4349
jonesash@musc.edu

Change_preferences

-- OR --

Create_login